Pharmaceuticals

Bacterial Vaginosis Drug Market was valued at US$ 2.15 Billion in 2024 and is expected to reach to US$ 3.82 Billion by 2031; it is estimated to record a CAGR of 8.3% from 2024 to 2031

• Pharmaceuticals

Bacterial Vaginosis Drug Market was valued at US$ 2.15 Billion in 2024 and is expected to reach to US$ 3.82 Billion by 2031; it is estimated to record a CAGR of 8.3% from 2024 to 2031

Market News Insights March 19, 2025

Rising prevalence of bacterial vaginosis, and the increased focus on developing novel and targeted therapies are contributing...

Read More Read more about Bacterial Vaginosis Drug Market was valued at US$ 2.15 Billion in 2024 and is expected to reach to US$ 3.82 Billion by 2031; it is estimated to record a CAGR of 8.3% from 2024 to 2031

Enteral Nutrition Market was valued at US$ 8,276.93 Million in 2022 and is expected to reach to US$ 13,204.19 Million by 2030; it is estimated to record a CAGR of 6.0% from 2022 to 2030

• Pharmaceuticals

Enteral Nutrition Market was valued at US$ 8,276.93 Million in 2022 and is expected to reach to US$ 13,204.19 Million by 2030; it is estimated to record a CAGR of 6.0% from 2022 to 2030

Market News Insights March 18, 2025

North America accounted for a major share of the global enteral nutrition market in 2022. Factors propelling...

Read More Read more about Enteral Nutrition Market was valued at US$ 8,276.93 Million in 2022 and is expected to reach to US$ 13,204.19 Million by 2030; it is estimated to record a CAGR of 6.0% from 2022 to 2030

Sickle Cell Disease Treatment Market was valued at US$ 1,160.16 Million in 2022 and is expected to reach to US$ 4,691.87 Million by 2030; it is estimated to record a CAGR of 19.1% from 2022 to 2030

• Pharmaceuticals

Sickle Cell Disease Treatment Market was valued at US$ 1,160.16 Million in 2022 and is expected to reach to US$ 4,691.87 Million by 2030; it is estimated to record a CAGR of 19.1% from 2022 to 2030

Market News Insights February 24, 2025

Extending Pipeline of New Drugs and Vaccines The R&D of new medicines is considered the best strategy...

Read More Read more about Sickle Cell Disease Treatment Market was valued at US$ 1,160.16 Million in 2022 and is expected to reach to US$ 4,691.87 Million by 2030; it is estimated to record a CAGR of 19.1% from 2022 to 2030

Radiopharmaceuticals Market was valued at US$ 9.07 Billion in 2023 and is expected to reach to US$ 26.51 Billion by 2031; it is estimated to record a CAGR of 14.4% from 2023 to 2031

• Pharmaceuticals

Radiopharmaceuticals Market was valued at US$ 9.07 Billion in 2023 and is expected to reach to US$ 26.51 Billion by 2031; it is estimated to record a CAGR of 14.4% from 2023 to 2031

Market News Insights February 20, 2025

Nuclear medicine is a field that is undergoing many changes. As radiopharmaceuticals evolve rapidly, more advanced diagnostic...

Read More Read more about Radiopharmaceuticals Market was valued at US$ 9.07 Billion in 2023 and is expected to reach to US$ 26.51 Billion by 2031; it is estimated to record a CAGR of 14.4% from 2023 to 2031

Epilepsy Market was valued at US$ 7.7 Billion in 2022 and is expected to reach to US$ 10.7 Billion by 2030; it is estimated to record a CAGR of 4.1% from 2022 to 2030

• Pharmaceuticals

Epilepsy Market was valued at US$ 7.7 Billion in 2022 and is expected to reach to US$ 10.7 Billion by 2030; it is estimated to record a CAGR of 4.1% from 2022 to 2030

Market News Insights February 19, 2025

Epilepsy is one of the most common chronic neurological disorders across the world. Associated with an abnormal...

Read More Read more about Epilepsy Market was valued at US$ 7.7 Billion in 2022 and is expected to reach to US$ 10.7 Billion by 2030; it is estimated to record a CAGR of 4.1% from 2022 to 2030

Epilepsy Drugs Market was valued at US$ 7,768.50 Million in 2022 and is expected to reach to US$ 10,705.48 Million by 2030; it is estimated to record a CAGR of 29.7% from 2022 to 2030

• Pharmaceuticals

Epilepsy Drugs Market was valued at US$ 7,768.50 Million in 2022 and is expected to reach to US$ 10,705.48 Million by 2030; it is estimated to record a CAGR of 29.7% from 2022 to 2030

Market News Insights February 12, 2025

Increasing Product Approvals Would Lead to Future Trends in Market In recent years, there has been a...

Read More Read more about Epilepsy Drugs Market was valued at US$ 7,768.50 Million in 2022 and is expected to reach to US$ 10,705.48 Million by 2030; it is estimated to record a CAGR of 29.7% from 2022 to 2030

Radiopharmaceutical Therapeutic Market was valued at US$ 2.71 Billion in 2023 and is expected to reach to US$ 7.30 Billion by 2031; it is estimated to record a CAGR of 13.1% from 2023 to 2031

• Pharmaceuticals

Radiopharmaceutical Therapeutic Market was valued at US$ 2.71 Billion in 2023 and is expected to reach to US$ 7.30 Billion by 2031; it is estimated to record a CAGR of 13.1% from 2023 to 2031

Market News Insights February 10, 2025

Radiopharmaceuticals precisely target and deliver high doses of radiation directly to the site of the disease. The...

Read More Read more about Radiopharmaceutical Therapeutic Market was valued at US$ 2.71 Billion in 2023 and is expected to reach to US$ 7.30 Billion by 2031; it is estimated to record a CAGR of 13.1% from 2023 to 2031

Human Vaccine Adjuvants Market was valued at US$ 1,571.41 Million in 2022 and is expected to reach to US$ 4,489.23 Million by 2030; it is estimated to record a CAGR of 14.0% from 2022 to 2030

• Pharmaceuticals

Human Vaccine Adjuvants Market was valued at US$ 1,571.41 Million in 2022 and is expected to reach to US$ 4,489.23 Million by 2030; it is estimated to record a CAGR of 14.0% from 2022 to 2030

Market News Insights February 3, 2025

North America accounted for the largest share of the global human vaccine adjuvants market in 2022, and...

Read More Read more about Human Vaccine Adjuvants Market was valued at US$ 1,571.41 Million in 2022 and is expected to reach to US$ 4,489.23 Million by 2030; it is estimated to record a CAGR of 14.0% from 2022 to 2030

Mediterranean Fish Vaccine Market was valued at US$ 96,323.46 Million in 2022 and is expected to reach to US$ 209,030.80 Million by 2030; it is estimated to record a CAGR of 10.2% from 2022 to 2030

• Pharmaceuticals

Mediterranean Fish Vaccine Market was valued at US$ 96,323.46 Million in 2022 and is expected to reach to US$ 209,030.80 Million by 2030; it is estimated to record a CAGR of 10.2% from 2022 to 2030

Market News Insights January 30, 2025

Based on region, the Mediterranean fish vaccine market is divided into France, Italy, Spain, Egypt, Greece, Turkey,...

Read More Read more about Mediterranean Fish Vaccine Market was valued at US$ 96,323.46 Million in 2022 and is expected to reach to US$ 209,030.80 Million by 2030; it is estimated to record a CAGR of 10.2% from 2022 to 2030

Paracetamol Market was valued at US$ 9,993.29 Million in 2022 and is expected to reach to US$ 14,254.44 Million by 2030; it is estimated to record a CAGR of 4.5% from 2022 to 2030

• Pharmaceuticals

Paracetamol Market was valued at US$ 9,993.29 Million in 2022 and is expected to reach to US$ 14,254.44 Million by 2030; it is estimated to record a CAGR of 4.5% from 2022 to 2030

Market News Insights January 24, 2025

In the paracetamol market report, North America accounted for the largest share of the global paracetamol market...

Read More Read more about Paracetamol Market was valued at US$ 9,993.29 Million in 2022 and is expected to reach to US$ 14,254.44 Million by 2030; it is estimated to record a CAGR of 4.5% from 2022 to 2030